ArticleMedicine2026
Clinical and toxicological trends in mad honey research: A global bibliometric analysis of scientific evolution (1954-2025).
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHoney derived from the nectar of Rhododendron species, known as "mad honey," possesses unique pharmacological and toxicological properties due to its grayanotoxin content. Prior investigations have largely comprised case reports and experimental studies, lacking a comprehensive overview of broader scientific trends. The present study addresses this gap by providing the first bibliometric analysis of the historical development, thematic directions, and scientific structure of the "mad honey" literature published between 1954 and 2025.
methodsData for this retrospective bibliometric analysis were collected from the Web of Science Core Collection database in January 2026. The search strategy used the keywords "mad honey," "grayanotoxin," "andromedotoxin," "rhodotoxin," and "asebotoxin," encompassing publications from 1954 to 2025, with no language restrictions.
resultsDuring the study period, 388 publications were identified across 214 journals, reflecting an annual growth rate of 1.65%. A total of 1253 authors contributed, with an average of 18.57 citations per publication. Country-level analysis revealed that Türkiye leads globally in both publication volume and citation impact, followed by the United States, China, and Japan.
conclusionsThis analysis demonstrates that the mad honey literature has evolved from local case reports toward global clinical research and potential therapeutic applications. Research on mad honey has expanded globally since 2010, with Türkiye leading clinical data and diagnostic protocols. Future studies should shift focus from poisoning cases toward therapeutic potential, product standardization, and safe dosage parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.